Pfizer Inc. et al v. Sinotherapeutics Inc.
| Pfizer Inc., PF Prism C.V., PBG Puerto Rico LLC and PF Prism IMB B.V. |
| Sinotherapeutics Inc. |
| C.P. Pharmaceuticals International C.V. |
| 1:2021cv01427 |
| October 6, 2021 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 29, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 13
REDACTED VERSION of #11 Answer to Complaint,, Counterclaim, by Sinotherapeutics Inc.. (Attachments: #1 Exhibit 1)(Weinblatt, Richard)
|
|
Filing 12
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sinotherapeutics Inc.. (Weinblatt, Richard)
|
|
Filing 11
[SEALED] ANSWER to #1 Complaint, , COUNTERCLAIM against C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V., Pfizer Inc. by Sinotherapeutics Inc.. (Attachments: #1 Exhibit 1)(Weinblatt, Richard)
|
|
Filing 10
NOTICE of Appearance by Richard Charles Weinblatt on behalf of Sinotherapeutics Inc. (Weinblatt, Richard)
|
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, Brent Batzer, and Lindsay Eastman filed by Sinotherapeutics Inc. Signed by Judge Leonard P. Stark on 11/3/21. (ntl)
|
|
Filing 9
MOTION for Pro Hac Vice Appearance of Attorney Shashank Upadhye, Yixin Tang, Brent Batzer, and Lindsay Eastman - filed by Sinotherapeutics Inc.. (Stamoulis, Stamatios)
|
|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME for Defendant to respond to the Complaint to November 30, 2021 filed by Sinotherapeutics Inc. Signed by Judge Leonard P. Stark on 10/27/21. (ntl)
|
|
Filing 8
STIPULATION TO EXTEND TIME for Defendant to respond to the Complaint to November 30, 2021 - filed by Sinotherapeutics Inc.. (Stamoulis, Stamatios)
|
|
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
|
|
Filing 7
AFFIDAVIT of Service for Summons, Complaint and related papers served on Sinotherapeutics Inc. on October 8, 2021, filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan)
|
|
Filing 6
Summons Issued with Magistrate Consent Notice attached as to Sinotherapeutics Inc. on 10/6/2021. (apk)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF Prism C.V., PF Prism IMB B.V., Pfizer Inc. (apk)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,937,181 B2. (apk)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/23/2021. Date of Expiration of Patent: 03/14/2034.Thirty Month Stay Deadline: 2/23/2024. (apk)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
|
|
Filing 1
COMPLAINT filed against Sinotherapeutics Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3715730.) - filed by Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V., PF Prism IMB B.V., PBG Puerto Rico LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(apk)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
